Scientists at the University of Cambridge are developing a machine learning tool to better predict individuals’ long-term risk of developing cardiovascular disease (CVD)—specifically, heart attack or stroke. 

CMS has launched a new app for consumers that provides direct access to some of the most-used content on the agency’s website. The app, dubbed “What’s Covered,” allows people with Original Medicare, caregivers and others to see if a certain service or medical item is covered by Medicare.

Google’s AI tool for diagnosing diabetic retinopathy is having trouble reading images while it's being tested in an Indian hospital, according to a report by The Wall Street Journal.

A Seattle-based startup, 98point6, is looking to become the Amazon of primary care, according to a profile by CNBC.

In order for AI technology to be safely incorporated into diagnostic and clinical decision support (CDS) software, stakeholders must first address its effectiveness and provide additional evidence for its usefulness in the clinical setting, according to Duke researchers.

Though AI continues to make great strides within radiology, some radiologists are still unprepared to educate medical students regarding its usage. This in turn may hinder medical students and trainees from pursuing radiology, according to a new editorial published in Academic Radiology.

A new not-for-profit startup aimed at producing generic drugs will introduce 20 products in 2019, Reuters reported. The supplier, Civica Rx, initially expected to offer just 14 drugs in 2019, but will now likely exceed that after working with companies to produce additional medicines, company officials told Reuters.

Planned Parenthood is now offering an AI-powered, sexual health chatbot designed to reach more young people who visit its website, the organization announced Thursday, Jan. 24.